Applied Therapeutics Inc (APLT)

05:58 AM

Shareholder Rights Advocates at Levi & Korsinsky Investigate Applied Therapeutics, Inc. (APLT) Regarding Possible Securities Fraud Violations - ACCESS Newswire

05:58 AM

05:28 AM

Applied Therapeutics, Inc. (NASDAQ:APLT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

05:28 AM

Jun 06, 2025

Applied Therapeutics, Inc. (NASDAQ:APLT) Short Interest Update - MarketBeat

Jun 06, 2025

Jun 06, 2025

Millennium Management LLC Grows Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat

Jun 06, 2025

Jun 05, 2025

Millennium Management LLC Boosts Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Jun 05, 2025

Jun 05, 2025

Class Action Filed Against Applied Therapeutics, Inc. (APLT)February 18, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

Jun 05, 2025

Jun 03, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. LawsuitAPLT - ACCESS Newswire

Jun 03, 2025

May 31, 2025

BNP Paribas Financial Markets Grows Stake in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

May 31, 2025

May 31, 2025

Janus Henderson Group PLC Sells 10,505,737 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat

May 31, 2025

May 27, 2025

Columbia Trustee Got Sued for Securities Fraud — Then Left Her Pharma Firm Under a Cloud - The Intercept

May 27, 2025

May 26, 2025

Janus Henderson Group PLC Decreases Stake in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

May 26, 2025

May 25, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Investors to Inquire about Securities Investigation - ACCESS Newswire

May 25, 2025

May 25, 2025

Price T Rowe Associates Inc. MD Sells 986,108 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat

May 25, 2025

May 24, 2025

William Blair Brokers Increase Earnings Estimates for APLT - MarketBeat

May 24, 2025

May 24, 2025

Applied Therapeutics (NASDAQ:APLT) Upgraded by Wall Street Zen to "Sell" Rating - MarketBeat

May 24, 2025

May 24, 2025

Applied Therapeutics (NASDAQ:APLT) Stock Rating Upgraded by Wall Street Zen - Defense World

May 24, 2025

May 23, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

May 23, 2025

May 23, 2025

Applied Therapeutics Inc (APLT): An Important Analyst Insights - Stocksregister

May 23, 2025

May 22, 2025

Applied Therapeutics, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT - ACCESS Newswire

May 22, 2025

May 21, 2025

Vestal Point Capital LP Acquires 10,355,000 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat

May 21, 2025

May 19, 2025

Retail Traders Cheer Applied Therapeutics Data On Rare Nerve Disease Drug - MSN

May 19, 2025

May 19, 2025

Applied Therapeutics’ Rare Disease Treatment Flunks in Late-Stage Trial - NewsBreak: Local News & Alerts

May 19, 2025

May 19, 2025

New top-line data from Phase II/III trial of govorestat in CMT-SORD - The Pharma Letter

May 19, 2025

May 19, 2025

Retail Traders Cheer Applied Therapeutics Data On Rare Nerve Disease Drug By Stocktwits - Investing.com India

May 19, 2025

May 19, 2025

Applied Therapeutics Presents Full 12-Month Clinical Results and - GuruFocus

May 19, 2025

May 18, 2025

APLT Shares Results from INSPIRE Trial on Govorestat at Peripher - GuruFocus

May 18, 2025

May 18, 2025

APLT Shares Results from INSPIRE Trial on Govorestat at Peripheral Nerve Society Meeting | APLT Stock News - GuruFocus

May 18, 2025

May 18, 2025

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting - The Manila Times

May 18, 2025

May 18, 2025

Applied Therapeutics Presents Full 12-Month Clinical - GlobeNewswire

May 18, 2025

May 18, 2025

Breakthrough in CMT Treatment: New Clinical Data Shows First-Ever Disease Progression Slowing in 24-Month Study - Stock Titan

May 18, 2025

May 18, 2025

Here's Why Amazon Is a Brilliant Buy Now (Hint: It's Not E-Commerce) - The Globe and Mail

May 18, 2025

May 18, 2025

Massive News for Apple Stock Investors! - The Globe and Mail

May 18, 2025

May 17, 2025

Brokerages Set Applied Therapeutics, Inc. (NASDAQ:APLT) PT at $6.10 - Defense World

May 17, 2025

May 17, 2025

Applied Therapeutics’ (APLT) “Sector Perform” Rating Reiterated at Royal Bank of Canada - Defense World

May 17, 2025

May 14, 2025

APLT: RBC Capital Reiterates Sector Perform Rating, Price Target Maintained | APLT Stock News - GuruFocus

May 14, 2025

May 14, 2025

APLT Reports Financial Position and Advances in Govorestat Resea - GuruFocus

May 14, 2025

May 14, 2025

Applied Therapeutics Reports First Quarter 2025 Financial Results | APLT Stock News - GuruFocus

May 14, 2025

May 14, 2025

Applied Therapeutics, Inc. SEC 10-Q Report - TradingView

May 14, 2025

May 14, 2025

Barclays PLC Sells 27,997 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

May 14, 2025

May 14, 2025

Applied Therapeutics Reports First Quarter 2025 Financial Results - The Manila Times

May 14, 2025

May 12, 2025

APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

May 12, 2025

May 12, 2025

Alyeska Investment Group L.P. Boosts Stock Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat

May 12, 2025

May 12, 2025

Shareholders that Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky about Pending Class ActionAPLT - ACCESS Newswire

May 12, 2025

May 12, 2025

Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your RightsAPLT - ACCESS Newswire

May 12, 2025